LONDON (Alliance News) - AstraZeneca PLC said Wednesday Chief Executive Officer Pascal Soriot and three non-executives at the drug maker bought shares in the FTSE 100-listed firm in a series of transaction on Monday and Tuesday.
Soriot - CEO since 2012 - acquired 17,100 London-listed shares at 5,825.5 pence each on Monday, worth GBP996,161.
Non-Executive Director Sheri McCoy bought 2,472 US-listed American depositary shares - equivalent to half a London-listed share - at USD38.178 each, worth USD94,376, on Monday.
Non-Executive Director Philip Broadley on Tuesday acquired 520 London-listed shares at GBP57.38 each, worth GBP29,838.
On Monday, Non-Executive Director Deborah DiSanzo bought 1,000 US-listed American depositary shares at USD38.3056 each, worth USD38,306.
Shares in AstraZeneca were 08% lower at 5,679.00 pence in London on Wednesday, shares in New York had closed at USD37.66 on Tuesday.
The holdings of Soriot of any of the non-executives after the transactions were not disclosed.
Astrazeneca (AZN)